Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOld Mutual Lim. Regulatory News (OMU)

Share Price Information for Old Mutual Lim. (OMU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 47.15
Ask: 47.55
Change: 0.05 (0.11%)
Spread: 0.40 (0.848%)
Open: 48.50
High: 48.50
Low: 47.05
Prev. Close: 47.45
OMU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Old Mutual plc announces results of Tender Offer

18 Jul 2018 09:50

RNS Number : 0202V
Old Mutual Limited
18 July 2018
 

Old Mutual Limited

(Incorporated in the Republic of South Africa)

Registration number: 2017/235138/06

ISIN: ZAE000255360

JSE Share Code: OMU

NSX Share Code: OMM

("Old Mutual")

 

Ref 24/18

18 July 2018

 

NOT FOR DISTRIBUTION TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED) ("U.S. PERSON") OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (TOGETHER, THE "UNITED STATES") OR INTO ANY OTHER JURISDICTION OR TO ANY OTHER PERSON WHERE OR TO WHOM IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

 

OLD MUTUAL SUBSIDIARY OLD MUTUAL PLC ANNOUNCES RESULTS OF TENDER OFFERS

 

Old Mutual notes that its subsidiary, Old Mutual plc, has announced the results of the tender offers (the "Offers") in respect of its £500,000,000 8 per cent. Subordinated Notes due 3 June 2021 (of which £340,884,000 is currently outstanding) (ISIN: XS0632932538) (the "2021 Securities") and its £450,000,000 7.875 per cent. Subordinated Notes due 3 November 2025 (of which £60,842,000 is currently outstanding) (ISIN: XS1312138750) (the "2025 Securities" and, together with the 2021 Securities, the "Securities") today, 18 July 2018.

The tender offers expired at 4:00 p.m., London time, on 17 July 2018.

Old Mutual plc has decided to accept for purchase all Securities validly tendered pursuant to the Offers. Settlement of the Offers is expected to take place on 19 July 2018, following which the nominal amount of the principal outstanding of the 2021 Securities shall be £72,102,000 and the nominal amount of the principal outstanding of the 2025 Securities shall be £44,889,000. Old Mutual plc will deploy approximately £334 million of its available liquidity in settlement of the Offers.

The premiums paid to incentivise take-up of the Offers will result in a charge to Old Mutual's consolidated profit and loss, and a corresponding decrease in its consolidated net asset value, of approximately £14 million (ZAR 248 million, based on a closing ZAR/GBP exchange rate on 17 July 2018 of 17.39). However, there will be no impact on Old Mutual's consolidated results from operations, adjusted headline earnings and return on net asset value, because these key performance indicators exclude the results and net assets of the Residual Old Mutual plc entities as non-core operations.

The body of Old Mutual plc's announcement relating to the results of the Offers (as published on the London Stock Exchange website) is set out below.

 

 

----------------------------------------------------------------------------------------------------------------------------------

RESULTs OF tender offers

 

Old Mutual plc (the "Company") hereby announces (i) the results of its any-and-all tender offer for its £500,000,000 8 per cent. Subordinated Notes due 3 June 2021 (ISIN: XS0632932538) (of which £340,884,000 is currently outstanding) (the "2021 Securities") and (ii) the results of its any-and-all tender offer for its £450,000,000 7.875 per cent. Subordinated Notes due 3 November 2025 (ISIN: XS1312138750) (of which £60,842,000 is currently outstanding) (the "2025 Securities" and, together with the 2021 Securities, the "Securities").

On 9 July 2018, the Company announced its invitation to holders of its 2021 Securities (the "2021 Securityholders") and to holders of its 2025 Securities (the "2025 Securityholders") to tender their Securities for purchase by the Company for cash (each an "Offer" and, together, the "Offers").

The Offers were made on the terms and subject to the conditions set out in the Tender Offer Memorandum dated 9 July 2018 (the "Tender Offer Memorandum"). Capitalised terms used in this announcement but not defined have the meanings given to them in the Tender Offer Memorandum.

The Offers expired at 4.00 p.m., London time, on 17 July 2018.

Results of the 2021 Offer

The principal amount of 2021 Securities validly tendered by 2021 Securityholders pursuant to the 2021 Offer was £268,782,000, representing 78.85% of the aggregate principal outstanding amount of the 2021 Securities. The Company has decided to accept for purchase all 2021 Securities validly tendered pursuant to the 2021 Offer. The 2021 Securities Acceptance Amount is £268,782,000.

Results of the 2025 Offer

The principal amount of 2025 Securities validly tendered by 2025 Securityholders pursuant to the 2025 Offer was £15,953,000, representing 26.22% of the aggregate principal outstanding amount of the 2025 Securities. The Company has decided to accept for purchase all 2025 Securities validly tendered pursuant to the 2025 Offer. The 2025 Securities Acceptance Amount is £15,953,000.

Settlement and cancellation

Settlement of the Offers is expected to take place on 19 July 2018 (the "Settlement Date").

All Securities which are purchased by the Company pursuant to the Offers will forthwith be cancelled. Following cancellation of such Securities, the aggregate principal amount outstanding of the 2021 Securities shall be £72,102,000 and the aggregate principal amount outstanding of the 2025 Securities shall be £44,889,000.

 

The Dealer Managers

Merrill Lynch International2 King Edward StreetLondon EC1A 1HQUnited Kingdom

Telephone: +44 20 7996 5420Attention: Liability Management GroupEmail: DG.LM_EMEA@baml.com

Nedbank Limited, London Branch1st FloorMillennium Bridge House2 Lambeth HillLondon EC4V 4GG

Telephone: +44 20 7002 3540Attention: Head of Legal and Head of ComplianceEmail: liability.management@nedbank.co.uk

 

 

The Tender Agent

Lucid Issuer Services LimitedTankerton Works12 Argyle WalkLondon WC1H 8HAUnited Kingdom

Telephone: + 44 20 7704 0880Attention: Thomas Choquet / Arlind BytyqiEmail: oldmutual@lucid-is.com

 

DISCLAIMER This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

 

----------------------------------------------------------------------------------------------------------------------------------

 

Enquiries

Investor Relations

Nwabisa Piki T: +27 (11) 217 1951

M: +27 (0)83 846 1474

E: npiki@oldmutual.com

Communications:

Tabby Tsengiwe T: +27 (11) 217 1953

M: +27 (0)60 547 4947

E: ttsengiwe@oldmutual.com

 

Notes to Editors

About Old Mutual Limited

Old Mutual is a premium African financial services group that offers a broad spectrum of financial solutions to retail and corporate customers across key markets segments in 17 countries. Old Mutual's primary operations are in South Africa and the rest of Africa, and it has niche businesses in Latin America and Asia. With over 170 years of heritage across sub-Saharan Africa, we are a crucial part of the communities we serve and broader society on the continent.

 

For further information on Old Mutual, and its underlying businesses, please visit the corporate website at www.oldmutual.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TENSFESAAFASELW
Date   Source Headline
17th Mar 20233:15 pmRNSDealings in securities on behalf of share trusts
17th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
16th Mar 202310:30 amRNSForm 8.3 - [Mediclinic International plc]
15th Mar 202312:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
14th Mar 20237:00 amRNSFinal Results
10th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
9th Mar 202311:00 amRNSForm 8.3 - Mediclinic International plc
8th Mar 202312:30 pmRNSForm 8.3 - Mediclinic International plc
3rd Mar 202310:00 amRNSForm 8.3 - [Mediclinic International plc]
2nd Mar 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
24th Feb 20237:00 amRNSVoluntary Trading Statement
23rd Feb 20237:00 amRNSDirector/PDMR Shareholding Correction
22nd Feb 20233:30 pmRNSDirector/PDMR Shareholding
7th Feb 202312:00 pmRNSForm 8.3 - [Mediclinic International plc]
3rd Feb 20231:00 pmRNSForm 8.3 - [Mediclinic International plc]
27th Jan 20231:30 pmRNSForm 8.3 - [Mediclinic International plc]
10th Jan 202311:30 amRNSForm 8.3 - [Mediclinic International plc]
5th Jan 202312:00 pmRNSForm 8.3 - Mediclinic International plc
21st Dec 20221:00 pmRNSForm 8.3 - [Mediclinic International plc]
16th Dec 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 20221:50 pmRNSForm 8.3 - Mediclinic International plc
15th Dec 202211:30 amRNSForm 8.3 - Micro Focus International plc
30th Nov 202212:00 pmRNSForm 8.3 - Mediclinic International plc
22nd Nov 20227:00 amRNSVoluntary Operating Update
21st Nov 20223:00 pmRNSImplementation of the Bula Tsela transaction
18th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
17th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
16th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
15th Nov 20221:00 pmRNSForm 8.3 - Mediclinic International plc
11th Nov 20221:30 pmRNSForm 8.3 - Mediclinic International plc
4th Nov 20223:10 pmRNSOld Mutual Bula Tsela Transaction
20th Oct 202212:00 pmRNSForm 8.3 - Mediclinic International plc
14th Oct 202211:00 amRNSForm 8.3 - Mediclinic International plc
13th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
12th Oct 20221:00 pmRNSForm 8.3 - Mediclinic International plc
6th Oct 202212:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:30 pmRNSForm 8.3 - Mediclinic International plc
29th Sep 20221:00 pmRNSDirectorate Change
23rd Sep 20223:00 pmRNSForm 8.3 - Mediclinic International plc
6th Sep 202210:30 amRNSDirector/PDMR Shareholding
6th Sep 20229:30 amRNSInterim Dividend Currency Equivalents
30th Aug 20227:00 amRNSUnaudited Interim Results and Dividend Declaration
19th Aug 20222:00 pmRNSForm 8.3 - Mediclinic International plc
16th Aug 202212:40 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:30 pmRNSForm 8.3 - Mediclinic International plc
12th Aug 20221:00 pmRNSResults of shareholder voting at GM
11th Aug 20227:00 amRNSTrading Statement
4th Aug 202212:00 pmRNSForm 8.3 - Mediclinic International plc
27th Jul 20222:30 pmRNSForm 8.3 - Mediclinic International plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.